Roland M. Schmid

Research interests

Publications

• A large randomised controlled intervention trial to prevent gastric cancer by eradication of Helicobacter pylori in Linqu County, China: baseline results and factors affecting the eradication

  Gut · 2015 · https://doi.org/10.1136/gutjnl-2015-309197

• Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma

  Nature Medicine · 2015 · https://doi.org/10.1038/nm.3952

• A next-generation dual-recombinase system for time- and host-specific targeting of pancreatic cancer

  Nature Medicine · 2014 · https://doi.org/10.1038/nm.3646

• Selective Requirement of PI3K/PDK1 Signaling for Kras Oncogene-Driven Pancreatic Cell Plasticity and Cancer

  Cancer Cell · 2013 · https://doi.org/10.1016/j.ccr.2013.01.023

• Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study

  The Lancet Oncology · 2012 · https://doi.org/10.1016/s1470-2045(12)70490-4

• Notch2 is required for progression of pancreatic intraepithelial neoplasia and development of pancreatic ductal adenocarcinoma

  Proceedings of the National Academy of Sciences · 2010 · https://doi.org/10.1073/pnas.1002423107

• gp130-Mediated Stat3 Activation in Enterocytes Regulates Cell Survival and Cell-Cycle Progression during Colitis-Associated Tumorigenesis

  Cancer Cell · 2009 · https://doi.org/10.1016/j.ccr.2009.01.002

• p300 Acts as a Transcriptional Coactivator for Mammalian Notch-1

  Molecular and Cellular Biology · 2001 · https://doi.org/10.1128/mcb.21.22.7761-7774.2001

• Suppression of NF-κB activity by sulfasalazine is mediated by direct inhibition of IκB kinases α and β

  Gastroenterology · 2000 · https://doi.org/10.1053/gast.2000.19458

• NF-κB2 Is a Putative Target Gene of Activated Notch-1 via RBP-Jκ

  Molecular and Cellular Biology · 1998 · https://doi.org/10.1128/mcb.18.4.2077

Current projects

No projects listed.